HALOTHANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Halothane, and when can generic versions of Halothane launch?
Halothane is a drug marketed by BH, Halocarbon, and Hospira. and is included in three NDAs.
The generic ingredient in HALOTHANE is halothane. There are four drug master file entries for this compound. Additional details are available on the halothane profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HALOTHANE?
- What are the global sales for HALOTHANE?
- What is Average Wholesale Price for HALOTHANE?
Summary for HALOTHANE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Clinical Trials: | 11 |
| Patent Applications: | 3,373 |
| DailyMed Link: | HALOTHANE at DailyMed |
Recent Clinical Trials for HALOTHANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | Phase 1/Phase 2 |
| University Hospital Olomouc | Phase 2 |
| The Institute of Molecular and Translational Medicine, Czech Republic | Phase 2 |
Medical Subject Heading (MeSH) Categories for HALOTHANE
Anatomical Therapeutic Chemical (ATC) Classes for HALOTHANE
US Patents and Regulatory Information for HALOTHANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bh | HALOTHANE | halothane | LIQUID;INHALATION | 084977-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Halocarbon | HALOTHANE | halothane | LIQUID;INHALATION | 080810-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | HALOTHANE | halothane | LIQUID;INHALATION | 083254-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
